Últimos Artículos de Metabolism Clinical and Experimental
- Hepatocyte DDIT4 aggravates MASH progression through GPX4-mediated ferroptosis
- Hyperinsulinemia drives glomerular podocyte injury and albuminuria via a self-perpetuating GSK3β–IRS1 insulin desensitization circuit
- Skeletal muscle-derived Metrnl induced by exercise displays the roles of endothelioprotective and anti-atherosclerosis in male mice through KIT/NFκB signaling
- 6-Phosphofructokinase-2/fructose-2,6-bisphosphatase 3: A potential target in the development of diabetes and its complications
- Editorial Board
- Circadian robustness and glycemic control: From wearable data to clinical implications
- Loss of cardiomyocyte AKT signaling causes deterioration of lipid metabolism and cellular atrophy
- Metformin suppresses β-cell apoptosis under ER stress by inhibiting protein translation
- When the proteome meets the metabolome observational and Mendelian randomization analyses
- Reply: From liver to vasculature: An integrated view of cardiovascular risk in hepatic steatosis
- GLP-1 receptor agonists and atrial fibrillation: Chronotropy, atrial substrate, and cardiometabolic mechanisms
- Reply to letter to the editor: Circadian robustness and glycemic control: From wearable data to clinical implications
- Bone marrow rewired: Trained immunity and clonal hematopoiesis in metabolic disease
- Serum Response Factor (SRF) promotes actin cytoskeletal organization in adipocytes to support adaptive hypertrophic expansion and tissue remodeling during obesity in mice
- Proteomics and metabolomics biomarkers for predicting the onset and progression of diabetic complications: A systematic review and bioinformatics integration
- Enduring improvements in hepatic insulin sensitivity predict sustained remission of prediabetes during a 3-year lifestyle intervention: results from the PREVIEW multinational diabetes prevention trial
- The heart rate paradox and inferential limits of the GLP-1 receptor agonist–atrial fibrillation association
- Metabolomics profiles of type 2 diabetes and insulin resistance and their associations with total mortality. T2D metabolites linked to mortality
- SREBP2 links ACSS2-dependent acetyl-CoA biosynthesis to metaboloepigenetic activation of hepatic stellate cells and liver fibrosis
- Large-scale plasma proteomics for predicting future cardiovascular and all-cause mortality among individuals with cardiovascular-kidney-metabolic syndrome stage 0–3